Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01VOU
|
|||
Former ID |
DNC013338
|
|||
Drug Name |
2,2',4,4',6'-pentahydroxychalcone
|
|||
Synonyms |
CHEMBL244249; 2,2',4,4',6'-pentahydroxychalcone; BDBM50203986
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H12O6
|
|||
Canonical SMILES |
C1=CC(=C(C=C1O)O)C=CC(=O)C2=C(C=C(C=C2O)O)O
|
|||
InChI |
1S/C15H12O6/c16-9-3-1-8(12(19)5-9)2-4-11(18)15-13(20)6-10(17)7-14(15)21/h1-7,16-17,19-21H/b4-2+
|
|||
InChIKey |
MDRJIGPMMMALHB-DUXPYHPUSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
BioCyc | (S)-reticuline biosynthesis | |||
Eumelanin biosynthesis | ||||
L-dopachrome biosynthesis | ||||
KEGG Pathway | Tyrosine metabolism | |||
Riboflavin metabolism | ||||
Metabolic pathways | ||||
Melanogenesis | ||||
Pathwhiz Pathway | Riboflavin Metabolism | |||
Tyrosine Metabolism | ||||
WikiPathways | Dopamine metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors. Bioorg Med Chem. 2007 Mar 15;15(6):2396-402. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.